Top Markets
#1 0G 0G +34.27%
#2 Zora Zora +23.49%
#3 Nockchain Nockchain +20.21%
#4 Fake World Assets Fake World Assets +19.05%
#5 Axelar Axelar +18.61%
#6 Full Moon Full Moon +17.70%
#7 Notcoin Notcoin +16.06%
#8 Merlin's Seal BTC Merlin's Seal BTC +15.95%
#9 ADO Protocol ADO Protocol +15.68%
#10 StonkBroker StonkBroker +15.35%
Coin of the day
0G 0G
設定
言語
日本
通貨
USD
テーマ
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
株式のランク #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
株価
$8.46
最終同期: 2026-08-28
時価総額
$514.33M
変化（1日）
-2.08%
変化（1年）
128.03%
国
US
取引 Kyverna Therapeutics, Inc. (KYTX)

カテゴリー

Healthcare
Kyverna Therapeutics, Inc.（KYTX）の株価履歴
終値の最高値: $8.33 （2026-08-01）

終値の最安値: $28.70 （2024-02-01）
Kyverna Therapeutics, Inc. の株価履歴（2024 ～ 2026）
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) -5.16%
2025 89.56%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.01 -13.08%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $752.76 6.28%
CH